@reon1
RAC hasn't submitted an NDA since 2019. They don't intend to submit another until 1H 2025.
The entire clinical strategy revolves around exploring the greatest ROI for investors for the least amount of outlay BEFORE committing to a US registrational trial. One of the reasons there's so few SOI.
The peadiatric AML PRV is one of numerous commercialisation strategies on offer. Shareholders are aware of this.
@reon1RAC hasn't submitted an NDA since 2019. They don't intend...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
0.015(0.92%) |
Mkt cap ! $278.6M | |||
| Open | High | Low | Value | Volume |
| $1.64 | $1.64 | $1.62 | $26.01K | 16.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5023 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 400 | 1 |
View Market Depth
| Last trade - 14.02pm 11/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |